Identification and characterization of m4 selective muscarinic antagonists
摘要:
Our interest in the area of m4 muscarinic antagonists has led us to study a series of benzoxazine isoquinolines. One of the most potent and selective compounds of this series is example 1 with an IC50 value of 90.7nM at m4 receptors, and 72-fold (m1), 38-fold (m2), 10-fold (m3), and 82-fold (m5) more selective compared to the other receptors. The synthesis and receptor binding affinity of analogs of 1 are reported. (C) 1998 Elsevier Science Ltd. All rights reserved.
Identification and characterization of m4 selective muscarinic antagonists
摘要:
Our interest in the area of m4 muscarinic antagonists has led us to study a series of benzoxazine isoquinolines. One of the most potent and selective compounds of this series is example 1 with an IC50 value of 90.7nM at m4 receptors, and 72-fold (m1), 38-fold (m2), 10-fold (m3), and 82-fold (m5) more selective compared to the other receptors. The synthesis and receptor binding affinity of analogs of 1 are reported. (C) 1998 Elsevier Science Ltd. All rights reserved.
FUNCTIONALIZED HETEROCYCLES AS CHEMOKINE RECEPTOR MODULATORS
申请人:WARNER-LAMBERT COMPANY
公开号:EP1144415A2
公开(公告)日:2001-10-17
[EN] FUNCTIONALIZED HETEROCYCLES AS CHEMOKINE RECEPTOR MODULATORS<br/>[FR] HETEROCYCLES FONCTIONNALISES EN TANT QUE MODULATEURS DES RECEPTEURS DE CHIMIOKINES
申请人:WARNER LAMBERT CO
公开号:WO2000042045A2
公开(公告)日:2000-07-20
The present invention is a novel series of functionalized heterocycles as chemokine receptor modulators of Formula (I) useful as modulators of chemokine receptor activity. The compounds are useful in the treatment and prevention of the AIDS virus. Intermediates useful in the prepartion of the final products, pharmaceutical compositions containing the final products are also taught.